Navigation Links
Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl
Date:2/19/2008

his study several indicators of iodine deficiency such as place of residence, history of thyroid diseases, and current urinary iodine excretion did not modify the risk of follicular adenoma.

Our findings confirm that follicular adenoma is strongly related to exposure from radioactive iodines, and while we found that the risk is modified by gender, age at exposure, place of residence, and personal history of thyroid diseases do not affect its subsequent development, said Dr. Zablotska.


'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Body image is stronger predictor of health than obesity, says Mailman School of PH study
2. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
3. Climate may increase heat-related deaths by 2050s, says Mailman School of PH study
4. Mailman School of Public Health study examines link between racial discrimination and substance use
5. Fixing Poor Vision Boosts Preschoolers Test Scores
6. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
7. FSDDS Creates New Sun Defense Essay Contest Throughout Florida Elementary Schools
8. Congresswoman Sutton Leads National Effort to Place Life-Saving AEDs in Americas Schools
9. IAS Teams Up with RiskWatch to Offer New Hospital Security and School Security Risk Assessments
10. A dangerous transition: High school to the first year of college
11. Friends school achievement influences high school girls interest in math

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ec. 3 The American Red ...ernational Brotherhood of Teamsters, Local 929 aft...ving the facility, interfering with blood shipment...wscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) ,... the American Red Cross Blood Services Penn-Jersey...
(Date:12/3/2009)...., Dec. 3 The Cancer Center at H... patients, Harrington Hospital announced today. ,...y," said Diane Becquart, Director of The Cancer Ce... today by the Massachusetts Department of Public H... facility. ,, The opening of The Cancer Center...
(Date:12/3/2009)...c. 3 /PRNewswire-Asia/ -- Long believed to provide...most important ingredients in global,cuisine, has ...son. , The timing of this ginger demand i... upward price pressures in a way that has speculat...ent demand hysteria over garlic. Garlic, also,beli...
(Date:12/3/2009)..., Md., Dec. 3 We are closer than e...ensures affordable, quality care for all. The Ame...ntact their representatives and voice their suppor...eo from ANA at: http://inr.mediaseed.tv/ANA_37124...system that focuses on wellness and prevention, a ...
(Date:12/3/2009)...ften play out at school and home, study finds , ...ool bullies are also likely to bully their brother...dy that included 195 children between the ages of ...ling no more than four years older or younger than...ullied at school or at home. The findings were pub...
Breaking Medicine News(10 mins):Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2Health News:VIDEO from Medialink and the American Nurses Association (ANA): American Nurses Association Urges All Americans to Take Part in Health Care Reform Debate 2Health News:Bullies May Intimidate Siblings, Too 2
... for Cancer Research (LICR) announced today that o...euticals, has licensed its lead cancer therapy can...bott. , The 806 antibody targets the EGFR cell s...me types of cancers. Current therapies that target...
...rticipants gathered this week for the sixth annual...ence. This year,s topic, "Complex Systems," drew s...sts, and philosophers to discuss new interdiscipli..., director, Center for Polymer Studies, Boston Uni...
...warns consumers about cosmetic injection discounts...008 -- Bargains on consumer goods and services may...ic times, however when related to cosmetic injecti...gain prices, deep discounts or purported sales on ...
...s report promising results for the viability of a ...t technique that may enhance the differential diag...tissue and normal skin in vivo. Recently publishe... and Surgery, the retrospective study discussed th...
...er patients who participate in intervention sessio... and altering health behaviors live longer than pa...rt. Published in the December 15, 2008 issue of C...reatment can have a significant impact on patients...
... DFMO may influence the extent of Barrett,s dyspla...study of this agent in a larger number of patients...sor of medicine and oncology at the Mayo Clinic, R...ontiers in Cancer Prevention Research. , The sin...
Other Medicine News:Health News:Conference on complexity offers new opportunities for interdisciplinary collaboration 2Health News:Beware Botox Bargains in Tough Economic Times 2Health News:Beware Botox Bargains in Tough Economic Times 3Health News:Beware Botox Bargains in Tough Economic Times 4Health News:Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue 2Health News:Future Looks Bright For Non-Invasive Diagnosis Of Skin Cancer; Study Shows Novel Light Device Detects Cancerous Lesions From Normal Tissue 3Health News:Psychological interventions associated with breast cancer survival 2Health News:DFMO may affect Barrett's esophagus 2
(Date:12/3/2009)... 3 Stryker Corporation (...rectors has authorized the Company to repurchase u..., timing and amount of any purchases will be deter...valuation of market conditions, stock price and ot...iderations. Purchases may be made from time to ti...
(Date:12/3/2009)...Dec. 3 Decision Resources, one o...focusing on pharmaceutical and healthcare issues, ...Brazil will grow from $417 million in 2008 to $834...growth rate is attributed to a growing prevalent a...eneration antidiabetics such as Merck,s Januvia, N...
(Date:12/3/2009)...c. 3 Honeywell (NYSE: HON ) anno...th Pro-Lab Laboratuar Teknolojileri, which will di...igh-purity solvents in Turkey. ,, Burdick &...ology and pharmaceutical companies in the drug dis...rowth rate of the Turkish pharmaceutical market is...
Breaking Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Benji Marley or Bo 3A Three Genes Dictate Dogs Coat 55573 1Benji Marley or Bo 3A Three Genes Dictate Dogs Coat 55573 2Researchers identify new cancer causing role for protein 55569 1Researchers identify new cancer causing role for protein 55569 2Magid Abou Gharbia Ph D FRSC Joins LAXAI as Scientific Advisor 13725 1Magid Abou Gharbia Ph D FRSC Joins LAXAI as Scientific Advisor 13725 2Magid Abou Gharbia Ph D FRSC Joins LAXAI as Scientific Advisor 13725 3
...(Nasdaq: PCOP ), an innovator in the discovery an..., today announced that Schering-Plough has,initiat...ith PS948115, a,compound identified from the colla...s being evaluated as a potential treatment for res...illion milestone payment from,Schering-Plough as a...
...e and With Lipitor(R), in, Overweight or Obese P... HAYWARD, Calif., Sept. 25 Metabolex, Inc., a,bi... development of novel,therapeutics for diabetes an...t it has begun a 180-patient Phase 2 trial of MBX-...lesterol and triglycerides to assess the drug,s,ef...
Other Medicine Technology:Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 2Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 3Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 4Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia 2
Beaupre Cilia Forceps
Ehrhardt Lid Forceps
Snellen Entropion Forceps - Small - Right
Francis Chalazion Forceps
Medicine Products: